adenocarcinoma
Showing NaN - NaN of 11
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)
Active, not recruiting
- Pancreatic Cancer
- Adenocarcinoma
-
Hamilton, Ontario, Canada
- +3 more
May 12, 2022
NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)
Active, not recruiting
- Non-Small Cell Lung Cancer
- +2 more
- AZD4547
- +10 more
-
Aberdeen, United Kingdom
- +24 more
Nov 2, 2021
Cervical Cancer, Squamous Cell Carcinoma, Adenosquamous Carcinoma Trial in Canada (CT Abdomen and Pelvis scan + whole body
Completed
- Cervical Cancer
- +3 more
- CT Abdomen and Pelvis scan + whole body PET-CT scan
- CT Abdomen and Pelvis scan
-
Hamilton, Ontario, Canada
- +5 more
Jan 28, 2020
Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)
Completed
- Gastric Cancer
- Adenocarcinoma
- ramucirumab
- +2 more
-
Bakersfield, California
- +160 more
Sep 10, 2019
Adenocarcinoma of the Rectum, Adenocarcinoma, Adenocarcinoma, Mucinous Trial in Worldwide (Patients who have surgery at 12 weeks
Unknown status
- Adenocarcinoma of the Rectum
- +16 more
- Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
-
Sao Paulo, Brazil
- +22 more
Sep 14, 2018
Molecular, Pathologic and MRI Investigation of Prognostic and
Unknown status
- Adenocarcinoma
- +15 more
-
Peterborough, Cambridgeshire, United Kingdom
- +18 more
Sep 13, 2018
NSCLC, Adenocarcinoma Trial in Worldwide (Pemetrexed, BIBW 2992, Cisplatin)
Completed
- Carcinoma, Non-Small-Cell Lung
- Adenocarcinoma
- Pemetrexed
- +2 more
-
Fayetteville, Arkansas
- +132 more
Mar 9, 2018
Barrett Syndrome, Barrett's Syndrome, Barrett's Esophagus Trial in France, United Kingdom, United States (Standard endoscopic
Completed
- Barrett Syndrome
- +4 more
- Standard endoscopic evaluation
- pCLE guided evaluation
-
Jacksonville, Florida
- +5 more
Mar 22, 2016
Non-Small-Cell Lung Carcinoma, Adenocarcinoma Trial in Worldwide (Bevacizumab, Carboplatin, Paclitaxel)
Completed
- Non-Small-Cell Lung Carcinoma
- Adenocarcinoma
- Bevacizumab
- +3 more
-
Baton Rouge, Louisiana
- +43 more
Oct 16, 2013